DNA Methylation-Based Biomarkers of Protein Levels and Cardiovascular Disease Risk: Opportunities and Challenges for Precision Cardiology.
作者信息
Bozack Anne K, Navas-Acien Ana, Cardenas Andres
机构信息
Department of Epidemiology and Population Health (A.K.B., A.C.), Stanford University School of Medicine, CA.
Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, NY (A.N.-A.).
出版信息
Circ Genom Precis Med. 2024 Apr;17(2):e004571. doi: 10.1161/CIRCGEN.124.004571. Epub 2024 Feb 13.
Abstract
摘要
相似文献
1
DNA Methylation-Based Biomarkers of Protein Levels and Cardiovascular Disease Risk: Opportunities and Challenges for Precision Cardiology.基于DNA甲基化的蛋白质水平生物标志物与心血管疾病风险：精准心脏病学的机遇与挑战
Circ Genom Precis Med. 2024 Apr;17(2):e004571. doi: 10.1161/CIRCGEN.124.004571. Epub 2024 Feb 13.
2
DNA methylation biomarkers of myocardial infarction and cardiovascular disease.心肌梗死和心血管疾病的DNA甲基化生物标志物。
Clin Epigenetics. 2021 Apr 21;13(1):86. doi: 10.1186/s13148-021-01078-6.
3
DNA methylation and incident cardiovascular disease.DNA 甲基化与心血管疾病事件。
Curr Opin Clin Nutr Metab Care. 2020 Jul;23(4):236-240. doi: 10.1097/MCO.0000000000000659.
4
Clinical applications of epigenetics in cardiovascular disease: the long road ahead.表观遗传学在心血管疾病中的临床应用：前路漫漫。
Transl Res. 2015 Jan;165(1):143-53. doi: 10.1016/j.trsl.2014.04.004. Epub 2014 Apr 8.
5
Clinical epigenomics for cardiovascular disease: Diagnostics and therapies.临床表观基因组学与心血管疾病：诊断与治疗。
J Mol Cell Cardiol. 2021 May;154:97-105. doi: 10.1016/j.yjmcc.2021.01.011. Epub 2021 Feb 6.
6
Blood-Based DNA Methylation Biomarkers to Identify Risk and Progression of Cardiovascular Disease.用于识别心血管疾病风险和进展的血液DNA甲基化生物标志物
Int J Mol Sci. 2025 Mar 6;26(5):2355. doi: 10.3390/ijms26052355.
7
New insights into the role of DNA methylation in cardiovascular disease.DNA甲基化在心血管疾病中作用的新见解。
Eur J Clin Invest. 2019 Feb;49(2):e13051. doi: 10.1111/eci.13051. Epub 2018 Dec 13.
8
DNA methylation modules associate with incident cardiovascular disease and cumulative risk factor exposure.DNA 甲基化模块与心血管疾病事件和累积风险因素暴露相关。
Clin Epigenetics. 2019 Oct 15;11(1):142. doi: 10.1186/s13148-019-0705-2.
9
Epigenetics for the pediatric cardiologist.儿科心脏病专家的表观遗传学
Congenit Heart Dis. 2017 Dec;12(6):828-833. doi: 10.1111/chd.12543. Epub 2017 Oct 5.
10
Epigenetic scores for the circulating proteome as tools for disease prediction.循环蛋白质组的表观遗传评分可作为疾病预测的工具。
Elife. 2022 Jan 13;11:e71802. doi: 10.7554/eLife.71802.
本文引用的文献
1
Epigenetic Contributions to Clinical Risk Prediction of Cardiovascular Disease.表观遗传学对心血管疾病临床风险预测的贡献。
Circ Genom Precis Med. 2024 Feb;17(1):e004265. doi: 10.1161/CIRCGEN.123.004265. Epub 2024 Jan 30.
2
Validation of the new EPIC DNA methylation microarray (900K EPIC v2) for high-throughput profiling of the human DNA methylome.验证新型 EPIC DNA 甲基化微阵列（900K EPIC v2）在高通量人类 DNA 甲基组分析中的应用。
Epigenetics. 2023 Dec;18(1):2185742. doi: 10.1080/15592294.2023.2185742.
3
DNA methylation GrimAge version 2.DNA 甲基化 GrimAge 版本 2.
Aging (Albany NY). 2022 Dec 14;14(23):9484-9549. doi: 10.18632/aging.204434.
4
Epigenetic Biomarkers of Lead Exposure and Cardiovascular Disease: Prospective Evidence in the Strong Heart Study.铅暴露与心血管疾病的表观遗传生物标志物：来自“强壮心脏研究”的前瞻性证据。
J Am Heart Assoc. 2022 Dec 6;11(23):e026934. doi: 10.1161/JAHA.122.026934. Epub 2022 Nov 16.
5
A computational solution for bolstering reliability of epigenetic clocks: Implications for clinical trials and longitudinal tracking.一种增强表观遗传时钟可靠性的计算解决方案：对临床试验和纵向跟踪的影响。
Nat Aging. 2022 Jul;2(7):644-661. doi: 10.1038/s43587-022-00248-2. Epub 2022 Jul 15.
6
How to Translate DNA Methylation Biomarkers Into Clinical Practice.如何将DNA甲基化生物标志物应用于临床实践。
Front Cell Dev Biol. 2022 Feb 23;10:854797. doi: 10.3389/fcell.2022.854797. eCollection 2022.
7
Epigenetic scores for the circulating proteome as tools for disease prediction.循环蛋白质组的表观遗传评分可作为疾病预测的工具。
Elife. 2022 Jan 13;11:e71802. doi: 10.7554/eLife.71802.
8
Blood DNA Methylation and Incident Coronary Heart Disease: Evidence From the Strong Heart Study.血液 DNA 甲基化与冠心病事件：来自“强健心脏研究”的证据。
JAMA Cardiol. 2021 Nov 1;6(11):1237-1246. doi: 10.1001/jamacardio.2021.2704.
9
Novel DNA methylation signatures of tobacco smoking with trans-ethnic effects.具有跨种族效应的新型吸烟 DNA 甲基化特征。
Clin Epigenetics. 2021 Feb 16;13(1):36. doi: 10.1186/s13148-021-01018-4.
10
Current status of development of methylation biomarkers for in vitro diagnostic IVD applications.用于体外诊断（IVD）应用的甲基化生物标志物的发展现状。
Clin Epigenetics. 2020 Jul 6;12(1):100. doi: 10.1186/s13148-020-00886-6.
Zotero 插件